Clinical Trials Directory

Trials / Unknown

UnknownNCT02963129

Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT

Treatment of Nasal Staphylococcus Aureus Colonization in Patients With Hereditary Hemorrhagic Telangiectasia With Recurrent Epistaxis.

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Hospital Italiano de Buenos Aires · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Compare the frequency of epistaxis and quality of life related to nasal bleeding in patients with HHT colonized with sataphylococo before and after being treated with mupirocin ointment.

Detailed description

Hereditary hemorrhagic telangiectasia is a vascular dysplasia characterized by the development of mucocutaneous telangiectasia and arteriovenous malformations in organs such as brain, lung, liver and tube digestivo. Is considered a rare disease, although It means that there is a substantial underdiagnosis. The overall prevalence is 1/5000. Approximately 60% of the general population hosts strains of Staphylococcus aureus (S. aureus) intermittently and are called intermittent carriers, 20% represent persistent carriers harboring the same strain of S. aureus and 20% of the population are never carriers. On this concept, one might think that HHT patients in whom there is an active and pathological vascular remodeling that causes bleeding, and inflammation is a known activator of abnormal angiogenesis; reducing an inflammatory factor as microbial through the eradication of nasal S. aureus could be useful to reduce bleeding in this population, directly impacting on quality of life.

Conditions

Interventions

TypeNameDescription
DRUGMupirocinMupirocin ointment in the nose for 5 days
OTHERPlaceboPlacebo ointment in the nose for 5 days

Timeline

Start date
2017-06-01
Primary completion
2017-06-01
Completion
2017-12-01
First posted
2016-11-15
Last updated
2016-11-15

Locations

2 sites across 1 country: Argentina

Source: ClinicalTrials.gov record NCT02963129. Inclusion in this directory is not an endorsement.